Clinical trial
TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable…
NCT00077688 · Achieve Life Sciences, Industry · Completed
Key facts
| NCT number | NCT00077688 |
|---|---|
| Title | TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium |
| Official title | A Phase 2 Multicenter Evaluation of the Safety and Efficacy of TOCOSOL(TM) Paclitaxel (S-8184 Paclitaxel Injectable Emulsion) in Patients With Metastatic or Locally Advanced, Unresectable Transitional Cell Carcinoma of the Urothelium |
| Lead sponsor | Achieve Life Sciences, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms, Carcinoma, Transitional Cell |
| Intervention type | Drug |
| Interventions | TOCOSOL Paclitaxel |
| Enrollment | 44 |
| Start date | Nov 1, 2003 |
| Completion | Sep 1, 2007 |
| First posted | Feb 16, 2004 |
| Last update posted | Jun 4, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: